| Line 22: |
Line 22: |
| | | | |
| | | | |
| − | ===Myasthenia gravis (MG)=== | + | ===[[Myasthenia Gravis]] (MG)=== |
| | | | |
| − | *'''Acquired'''
| |
| − | **Autoimmune disease
| |
| − | ***Antibodies directed against acetyl choline receptors
| |
| − | **Associated with [[Thymus neoplasia|thymomas]], [[Megaoesophagus|megaoesophagus]] and dysphagia
| |
| − | **In adult dogs
| |
| − | *'''Congenital'''
| |
| − | **Inherited deficiency in acetyl choline receptors
| |
| − | **Rare
| |
| − | **Newfoundland, Jack Russel Terrier, Springer Spaniels – genetic predisposition
| |
| − | **In dogs – 4 DLA genes recognized: DLA-12, DLA-88, DLA-79 and DLA-64
| |
| − | **Associated with HLA gene in humans
| |
| − | **No antibodies against acetyl choline receptors in serum
| |
| − | **Non-specific muscle [[Muscles Degenerative - Pathology#Atrophy|disuse atrophy]] and fibrosis or no changes on histology
| |
| − | *Both forms manifest as weakness which worsens on exercise
| |
| − |
| |
| − | [[Category:Muscles - Developmental Pathology]]
| |
| | | | |
| | | | |